Rate My Professor Charles Douglas

Douglas completed his PhD in 2012 on medical law and end-of-life decision-making, and has authored more than 30 peer-reviewed papers across ethics, clinical decision-making, basic science, surgery, and oncology. Key publications include "Oncology patients' and oncology nurses' views on palliative chemotherapy: a cross-sectional comparison" (Collegian, 2021), "Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer" (Breast, 2019), "Informed consent guidelines for ionising radiation examinations: A Delphi study" (Radiography, 2020), "Addiction medicine ethics: relapse, no lapse and the struggle to treat addicts like everyone else" (Internal Medicine Journal, 2017), and "Moral concerns with sedation at the end of life" (Journal of Medical Ethics, 2014). He has received awards such as the College Medal (2021), Sir Edwin Hughes Memorial Research Prize (1999), inaugural General Surgeons Australia Best Paper Prize (1999), Ethel and Olive Hewitt Medical Research Scholarship (2001), and Royal Australasian College of Surgeons Research Scholarship (1999). A Fellow of the Royal Australasian College of Surgeons, he has worked as a consultant surgeon in breast cancer and melanoma surgery at the Breast Centre, Gateshead, directed the Newcastle Melanoma Unit (2010-2015), and currently serves as Clinical Director of Voluntary Assisted Dying for the Hunter New England Local Health District (since 2023).